InsidersTradesSigma
Browse the complete record of transactions filed by Seyedkazemi Setareh, Directeur du Développement. Director active across 1 companies, notably Adverum Biotechnologies, Inc.. Aggregated, 1 reports have been recorded. Total volume traded: €16k. The latest transaction was disclosed on 23 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Setareh Seyedkazemi serves as the Chief Development Officer at Adverum Biotechnologies, Inc. She is responsible for leading strategic development initiatives and innovation within the company. Her role involves identifying new growth opportunities and overseeing product development. Setareh Seyedkazemi plays a key role in Adverum Biotechnologies, Inc.'s mission to transform healthcare through biotechnology.